Prot #EMR 100070-001: A Phase I, Open-Label, Multiple-Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Subjects with Metastatic or Locally Advanced Solid Tumors a

Project: Research project

Project Details

StatusFinished
Effective start/end date12/10/15 → 12/10/21

Funding

  • Quintiles, Inc. (Prot #EMR 100070-001 // Prot #EMR 100070-001)
  • EMD Serono, Inc. (Prot #EMR 100070-001 // Prot #EMR 100070-001)